Affitech to Play Key Role in Major EU Embryonal Tumor Pipeline Project

Affitech announced that it has been selected to participate in the new European Union E.E.T. Pipeline project to identify fully human therapeutic antibody candidates for Embryonal Tumors (ET) by using its unique antibody discovery platform.

Source: Affitech